$168.79
—
AUM
$7.95B
NAV
—
Expense Ratio
—
Yield
0.21%
52W High
$179.64
52W Low
$120.33
Top Holdings (50)
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | BlackRock Cash Funds: Institutional, SL Agency Shares | — | 9.6974% |
| 2 | Vertex Pharmaceuticals, Inc. | — | 8.6536% |
| 3 | Gilead Sciences, Inc. | — | 8.0727% |
| 4 | Amgen, Inc. | — | 7.8417% |
| 5 | Regeneron Pharmaceuticals, Inc. | — | 6.9047% |
| 6 | Alnylam Pharmaceuticals, Inc. | — | 4.5616% |
| 7 | Insmed, Inc. | — | 3.2357% |
| 8 | Argenx SE | — | 3.0089% |
| 9 | Natera, Inc. | — | 2.6599% |
| 10 | Biogen, Inc. | — | 2.2785% |
| 11 | BeOne Medicines Ltd. | — | 1.9420% |
| 12 | United Therapeutics Corp. | — | 1.7891% |
| 13 | Illumina, Inc. | — | 1.7220% |
| 14 | Incyte Corp. | — | 1.6956% |
| 15 | Genmab A/S | — | 1.3388% |
| 16 | Neurocrine Biosciences, Inc. | — | 1.2172% |
| 17 | Revolution Medicines, Inc. | — | 1.1639% |
| 18 | Medpace Holdings, Inc. | — | 1.1220% |
| 19 | Bridgebio Pharma, Inc. | — | 1.1126% |
| 20 | Ionis Pharmaceuticals, Inc. | — | 1.1109% |
| 21 | Madrigal Pharmaceuticals, Inc. | — | 1.0619% |
| 22 | Exelixis, Inc. | — | 1.0061% |
| 23 | BioMarin Pharmaceutical, Inc. | — | 0.9945% |
| 24 | Moderna, Inc. | — | 0.9036% |
| 25 | Avidity Biosciences, Inc. | — | 0.8806% |
| 26 | Ascendis Pharma A/S | — | 0.8731% |
| 27 | Charles River Laboratories International, Inc. | — | 0.8576% |
| 28 | Roivant Sciences Ltd. | — | 0.8300% |
| 29 | Bio-Techne Corp. | — | 0.8001% |
| 30 | Repligen Corp. | — | 0.7707% |
| 31 | Arrowhead Pharmaceuticals, Inc. | — | 0.7392% |
| 32 | Halozyme Therapeutics, Inc. | — | 0.6913% |
| 33 | Cytokinetics, Inc. | — | 0.6739% |
| 34 | Axsome Therapeutics, Inc. | — | 0.6677% |
| 35 | Abivax SA | — | 0.6290% |
| 36 | Praxis Precision Medicines, Inc. | — | 0.6117% |
| 37 | Rhythm Pharmaceuticals, Inc. | — | 0.5895% |
| 38 | BioNTech SE | — | 0.5785% |
| 39 | Krystal Biotech, Inc. | — | 0.5426% |
| 40 | Tempus AI, Inc. | — | 0.5308% |
| 41 | PTC Therapeutics, Inc. | — | 0.5177% |
| 42 | Vaxcyte, Inc. | — | 0.5172% |
| 43 | Protagonist Therapeutics, Inc. | — | 0.4566% |
| 44 | Bruker Corp. | — | 0.4292% |
| 45 | Nuvalent, Inc., Class A | — | 0.4261% |
| 46 | CRISPR Therapeutics AG | — | 0.4238% |
| 47 | Kymera Therapeutics, Inc. | — | 0.4102% |
| 48 | Alkermes plc | — | 0.3987% |
| 49 | ACADIA Pharmaceuticals, Inc. | — | 0.3943% |
| 50 | Cogent Biosciences, Inc. | — | 0.3863% |
Last synced May 26, 2026, 6:13 AM · Price and AUM from Yahoo Finance · Holdings from SEC N-PORT filings